AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Emsita-M SR100/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Emsita-M SR100/1000 Tablet

Diabexe Duo 100/1000 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lowering heart attack and stroke risk. Diabexe Duo 100/1000 may be used independently or alongside other diabetes treatments. Optimal results require a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under physician guidance. Adherence to your doctor's dietary and exercise plan is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, particularly when combined with insulin or sulfonylureas; learn to identify and treat this. This medication isn't for everyone. Inform your doctor of any prior heart, liver, or kidney issues, pancreatic problems, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their physician. Other medications might interact with Diabexe Duo 100/1000; disclose all medications to ensure safety. Limit alcohol intake to avoid further blood glucose reduction. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Emsita-M SR100/1000 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Emsita-M SR100/1000 Tablet

Managing type 2 diabetes

Major Benefits of Emsita-M SR100/1000 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Emsita-M SR100/1000 Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.

Common Side effects of Emsita-M SR100/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Emsita-M SR100/1000 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Emsita-M SR100/1000 Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.

How Emsita-M SR100/1000 Tablet works:

Emsita-M SR100/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Emsita-M SR100/1000 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Emsita-M SR100/1000 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Emsita-M SR100/1000 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms appear.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Emsita-M SR100/1000 Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Emsita-M SR100/1000 Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Emsita-M SR100/1000 tablets is likely contraindicated for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Emsita-M SR100/1000 Tablet :

Should you forget to take your Emsita-M SR100/1000 Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Emsita-M SR100/1000 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Medication

FAQs on Emsita-M SR100/1000 Tablet

Emsita-M SR100/1000 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Emsita-M SR100/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Emsita-M SR100/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Emsita-M SR100/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol with Emsita-M SR100/1000 Tablet is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Emsita-M SR100/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Emsita-M SR100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Emsita-M SR100/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Emsita-M SR100/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita-M SR 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Emsita-M SR100/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Emsita-M SR100/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication safely, ensuring it's inaccessible to children, pets, and others.
Emsita-M SR100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Emsita-M SR100/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Emsita-M SR100/1000 Tablets are contraindicated in patients with allergies to any ingredient, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita-M SR 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Emsita-M SR100/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Emsita-M SR100/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Emsita-M SR100/1000 Table...
180
MRP 209
13% off